Colin Walsh

Insider profile

Performance

Overall performance
2.7

Performance over holding periods
2.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 38% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Colin Walsh's trades of Fusion Antibodies PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-10-16 2024-10-15 B Purchase
68,599
414.01
£3,365,759
68,599 414.01 £3,365,759
2024-02-14 2024-02-14 B Purchase
56,062
363.73
£118,733
56,062 363.73 £118,733